Application of polymyxin B convalently immobilized fiber in patients with septic shock

Insights

Polymyxin B immobilized fiber (PMX) effectively removes endotoxin, a key factor in sepsis and septic shock. This review details PMX design, clinical use, and patient outcomes, highlighting its role in intensive care.

Area of Science:

  • Critical Care Medicine
  • Biomedical Engineering
  • Infectious Diseases

Background:

  • Sepsis and septic shock are leading causes of death in intensive care units.
  • Endotoxin from Gram-negative bacteria plays a crucial role in sepsis pathogenesis.
  • Effective treatments targeting endotoxin are vital for improving patient survival.

Purpose of the Study:

  • To review the design and development of polymyxin B covalently immobilized fiber (PMX).
  • To discuss the clinical application and efficacy of PMX in treating sepsis.
  • To analyze the clinical outcomes associated with PMX therapy.

Main Methods:

  • Review of literature on PMX adsorbent technology.
  • Analysis of studies detailing PMX design and manufacturing processes.
  • Examination of clinical trial data and case reports on PMX application.

Main Results:

  • PMX demonstrates effective endotoxin adsorption capabilities.
  • Clinical studies show improved patient outcomes in sepsis and septic shock treated with PMX.
  • PMX therapy is associated with reduced mortality and morbidity.

Conclusions:

  • Polymyxin B immobilized fiber (PMX) is a promising therapeutic option for sepsis and septic shock.
  • PMX effectively neutralizes endotoxin, mitigating its harmful effects.
  • Further research and widespread clinical adoption of PMX could significantly impact intensive care outcomes.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...